Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCA | P17252 | 2/20 | 0.56 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.56 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.56 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.56 |
| ▸ | DGKA | P23743 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 3/20 | 0.51 |
| ▸ | TERT | O14746 | 3/20 | 0.51 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.51 |
| ▸ | PPARG | P37231 | 3/20 | 0.51 |
| ▸ | PPARD | Q03181 | 3/20 | 0.51 |
| ▸ | PPARA | Q07869 | 3/20 | 0.51 |
| ▸ | MAPT | P10636 | 2/20 | 0.51 |
| ▸ | BLM | P54132 | 2/20 | 0.51 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.51 |
| ▸ | FABP4 | P15090 | 2/20 | 0.51 |
| ▸ | GMNN | O75496 | 1/20 | 0.51 |
| ▸ | USP2 | O75604 | 1/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.51 |
| ▸ | POLB | P06746 | 1/20 | 0.51 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18206181 | 1.00 | PRKCA (0.56) | PRKCAPRKCEPRKCQPRKCDDGKA | |
| SCHEMBL18206180 | 1.00 | PRKCA (0.56) | PRKCAPRKCEPRKCQPRKCDDGKA | |
| SCHEMBL18206177 | 1.00 | PRKCA (0.56) | PRKCAPRKCEPRKCQPRKCDDGKA | |
| SCHEMBL23397747 | 0.94 | PRKCA (0.58) | PRKCAPRKCEPRKCQPRKCDDGKA | |
| SCHEMBL18218950 | 0.94 | PRKCA (0.58) | PRKCAPRKCEPRKCQPRKCDDGKA | |
| SCHEMBL18206785 | 0.94 | PRKCA (0.58) | PRKCAPRKCEPRKCQPRKCDDGKA | |
| SCHEMBL18206784 | 0.94 | PRKCA (0.58) | PRKCAPRKCEPRKCQPRKCDDGKA | |
| SCHEMBL18206782 | 0.94 | PRKCA (0.58) | PRKCAPRKCEPRKCQPRKCDDGKA | |
| SCHEMBL19821494 | 0.91 | LMNA (0.61) | PRKCAPRKCEPRKCQPRKCDDGKA | |
| SCHEMBL19821495 | 0.91 | LMNA (0.61) | PRKCAPRKCEPRKCQPRKCDDGKA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11020386-B2 | Methods and compositions for preventing opioid abuse | ALBANY MOLECULAR RESEARCH, INC. (US) | 2021-06-01 | — | — | US | disclosed |
| CN-111118901-A | Textile fabric with antibacterial and anti-inflammatory functions | 白中华 | 2020-05-08 | — | — | CN | disclosed |
| US-9040638-B2 | Use of hydroxycarboxylic acid oligomers as adhesives, manufacturing method and hydroxycarboxylic acid oligomers obtained | VALAGRO CARBONE RENOUVELABLE POITOU-CHARENTES (FR) | 2015-05-26 | — | — | US | disclosed |
| US-20120219709-A1 | USE OF HYDROXYCARBOXYLIC ACID OLIGOMERS AS ADHESIVES, MANUFACTURING METHOD AND HYDROXYCARBOXYLIC ACID OLIGOMERS OBTAINED | VALAGRO CARBONE RENOUVELABLE POITOU-CHARENTES (FR) | 2012-08-30 | — | — | US | disclosed |
| EP-1342462-B1 | O/W EMULSION COMPOSITION AND METHOD OF PREPARING THE SAME | OTSUKA PHARMA CO LTD (JP) | 2007-04-11 | — | — | EP | disclosed |
| US-6946436-B2 | O/W emulsion composition and method of preparing the same | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2005-09-20 | — | — | US | disclosed |
| US-20040029761-A1 | O/W emulsion composition and method of preparing the same | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2004-02-12 | — | — | US | disclosed |
| EP-1342462-A1 | O/W EMULSION COMPOSITION AND METHOD OF PREPARING THE SAME | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2003-09-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120219709-A1 | USE OF HYDROXYCARBOXYLIC ACID OLIGOMERS AS ADHESIVES, MANUFACTURING METHOD AND HYDROXYCARBOXYLIC ACID OLIGOMERS OBTAINED | HCAR1, HCAR2, HCAR3 | PRKCA 1480/4885PRKCE 2022/4885PRKCQ 3448/4885 |
| US-11020386-B2 | Methods and compositions for preventing opioid abuse | OPRM1, OPRK1, OPRD1 | PRKCA 3337/4885PRKCE 3943/4885PRKCQ 2854/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.